4//SEC Filing
Parsons James T. 4
Accession 0001235802-25-000005
CIK 0001401040other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:46 PM ET
Size
7.8 KB
Accession
0001235802-25-000005
Insider Transaction Report
Form 4
Parsons James T.
Director
Transactions
- Award
Stock Option (right to buy)
2025-01-02+4,287→ 4,287 totalExercise: $5.51Exp: 2035-01-01→ Common Shares (4,287 underlying) - Award
Voting Common Shares, no par value per share
2025-01-02$5.34/sh+15,917$84,997→ 75,854 total
Footnotes (3)
- [F1]These shares are issuable upon vesting and settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $85,000. The deferred stock units will vest in four nearly equal installments on each of March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025.
- [F2]Includes 3,850 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 69,754 shares issuable upon vesting and settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, as amended from time to time.
- [F3]Vests in two nearly equal installments on each of March 1, 2025 and June 1, 2025.
Documents
Issuer
DiaMedica Therapeutics Inc.
CIK 0001401040
Entity typeother
Related Parties
1- filerCIK 0001759855
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:46 PM ET
- Size
- 7.8 KB